cancer chemotherapy cancer pharmacology drugs on cancer new drug for cancer

1. CANCER
CHEMOTHERAPY
BY
SHARAD PATANGE
M.Pharm 1st year
School of Pharmacy
S.R.T.M.U. NANDED

30. Drug Name Generic Mode of Action Indication
Opdivo Nivolumab PD-1 inhibitor Melanoma
Lynparza Olaparib PARP inhibitor Ovarian cancer
Blincyto Blinatumomab CD19 and CD3 ALL
Akinzeo Netupitant Nausea in
Chemotherapy
Keytruda Pembrolizuma
b
PD-1 inhibitor Melanoma
Zydelig Idelalisib PI3K d inhibitor blood cancers
Drugs Approved by the FDA in 2014

31. Drug Name Generic Mode of Action Indication
Rubraca Rucaparib BRCA mutation Ovarian cancer
Darzalex Daratumumab Multiple
myeloma
Opdivo Nivolumab Head neck cancer
Keytruda Pembrolizumab PD-L1 Inhibitor NSCLC
Tecentriq Atezolizumab EGFR inhibitor NSCLC
Drugs Approved by the FDA in 2016

32. Drug Name Generic Mode of Action Indication
Verzenio abemaciclib Breast cancer
Mylotarg Gemtuzumab CD-33 AML
Besponsa Inotuzumab ALL
Imbruvica Ibrutinib cGVHD
Kisqali Ribociclib CDK 4 inhibitor Breast cancer
Drugs Approved by the FDA in 2017

33. Drug Name Generic Mode of Action Indication
Gilotrif Afatinib Protein kinase
inhibitor
Lung cancer
Lynparza Olaparib PRPA inhibitor Breast cancer
Drugs Approved by the FDA in 2018